Literature DB >> 23797869

Cancer: Importance of oncofetal gene, SALL4, in a subset of hepatocellular carcinoma.

Isobel Leake.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23797869     DOI： 10.1038/nrgastro.2013.115

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

Authors:  Kol Jia Yong; Chong Gao; Joline S J Lim; Benedict Yan; Henry Yang; Todor Dimitrov; Akira Kawasaki; Chee Wee Ong; Kwong-Fai Wong; Sanghoon Lee; Sharada Ravikumar; Supriya Srivastava; Xi Tian; Ronnie T Poon; Sheung Tat Fan; John M Luk; Yock Young Dan; Manuel Salto-Tellez; Li Chai; Daniel G Tenen
Journal:  N Engl J Med       Date:  2013-06-13       Impact factor: 91.245
  1 in total
  2 in total

1.  Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.

Authors:  Su-xia Han; Jun-lan Wang; Xi-jing Guo; Chen-chen He; Xia Ying; Jin-lu Ma; Yuan-yuan Zhang; Qian Zhao; Qing Zhu
Journal:  J Immunol Res       Date:  2014-04-17       Impact factor: 4.818

2.  SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.

Authors:  Mei Chen; Lu Li; Peng-Sheng Zheng
Journal:  Cancer Sci       Date:  2019-08-16       Impact factor: 6.716
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.